Cytokine Activation of Endothelial Cells: New Molecules for an Old Paradigm

• References

• 1 Mantovani A, Bussolino F, and Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bed side. Immunol Today. 1997. in press
• 2 Mantovani A, and Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989; 10: 370-375
• 3 Mantovani A, Bussolino F, and Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 06: 2591-2599
• 4 Bussolino F, and Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem 1995; 229: 327-337
• 5 Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, and Camussi G. Tumor necrosis factor alpha- induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994; 180: 377-382
• 6 De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA J, Shin Ws, and Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68
• 7 Peng HB, Rajavashisth TB, Libby P, and Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995; 270: 17050-17055
• 8 Zeiher AM, Fisslthaler B, Schray UtzB, and Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995; 76: 980-986
• 9 Peng HB, Libby P, and Liao JK. Induction and stabilization of I kappa B alpha by niric oxide mediates inhibition of NFkappa B. J Biol Chem 1995; 270: 14214-14219
• 10 Kilgore KS, Shen JP, Miller BF, Ward PA, and Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995; 155: 1434-1441
• 11 Saadi S, Holzknecht RA, Patte C, Stern DM, and Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182: 1807-1814
• 12 Breviario F, d’Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M, Della Valle G, Dejana E, Mantovani A, and Introna M. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267: 22190-22197
• 13 Introna M, Vidal Alles V, Castellano M, Picardi G, De Gioia L, Bottazzi B, Peri G, Breviario F, Salmona M, De Gregorio L, Dragani TA, Srinivasan N, Blundell TL, Hamilton TA, and Mantovani A. Cloning of mouse PTX3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 1996; 87: 1862-1872
• 14 Pober J, and Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-451
• 15 Maier JA, Statuto M, and Ragnotti G. Endogenous interleukin alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 1994; 14: 1845-1851
• 16 Bradley JR, Thiru S, and Pober JS. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995; 146: 27-32
• 17 Mackay F, Loetscher H, Stueber D, Gehr G, and Lesslauer W. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993; 177: 1277-1286
• 18 Paleolog EM M, Delasalle SA, Buurman WA, and Feldmann A. Functional activities of receptors for tumor necrosis factor- alpha on human vascular endothelial cells. Blood 1994; 84: 2578-2590
• 19 Grell M, Douni E, Wajant H, Löheden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, and Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802
• 20 Schmid EF, Binder K, Grell M, Scheurich P, and Pfizenmaier K. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood 1995; 86: 1836-1841
• 21 Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, and KunkeL SL. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte endothelial cell interactions. Blood 1995; 86: 2767-2773
• 22 Colotta F, Dower SK, Sims JE, and Mantovani A. The type II ‘decoy’ receptor: novel regulatory pathway for interleukin-1. Immunol Today 1994; 15: 562-566
• 23 Grosset C, Jazwiec B, Taupin JL, Liu H, Richard S, Mahon FX, Reiffers J, Moreau JF, and Ripoche J. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 1995; 86: 3763-3770
• 24 Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Gairone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Mahapatra BD, Rouvier E, Goldstein P, Banchereau J, and Lebecque S. T- cell IL-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593-2603
• 25 Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, and Stem D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995; 270: 11463-11471
• 26 Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, Van Damme J, Dejana E, and Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 549-553
• 27 Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, Van Hinsberg V, Sozzani S, Bussolino F, Poli V, Ciliberto G, and Mantovani A. IL-6, in concert with soluble IL-6 receptor, selectively induces chemokine production in endothelial cells and participates in the leukocyte recruitment in vivo. Immunity; 1997. in press
• 28 Bussolino F, Bocchietto E, Silvagno F, Soldi R, Arese M, and Mantovani A. Actions of molecules which regulate hemopeiesis on endothelial cells: memoirs of common ancestors?. Path Res Pract 1994; 190: 834-839
• 29 Korpelainen EI, Gamble JR, Smith WB, Dottore M, Vadas MA, and Lopez AF. Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatibility complex class II expression and cytokine production. Blood 1995; 86: 176-182
• 30 Sironi M, Munoz C, Pollicino T, Siboni A, Sciacca FL, Bemasconi S, Vecchi A, Colotta F, and Mantovani A. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur J Immunol 1993; 23: 2692-2695
• 31 Chen CC, and Manning AW. TGF-betal, IL-10 and IL-4 differentially modulate the cytokine-induced expression of the IL-6 and IL-8 in human endothelial cells. Cytokine 1996; 8: 58-65
• 32 Debeaux AC, Maingay JP, Ross JA, Fearon KC H, and Carter DC. Interleukin-4 and interleukin-10 increase endotoxin- stimulated human umbilical vein endothelial cell interleukin-8 release. J Interferon Cytokine Res 1995; 15: 441-445
• 33 Vora M, Yssel H, de Vries JE, and Karasek MA. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10. J Immunol 1994; 152: 5734-5741
• 34 Schoedon G, Schneemann M, Blau N, Edgell CJ, and Schaffner A. Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: new perspectives on endothelium-derived relaxing factor. Biochem Biophys Res Commun 1993; 196: 1343-1348
• 35 Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bomkamm GM, and Holler E. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endoxin. Blood 1995; 86: 4184-4193
• 36 Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett 1995; 45: 61-65
• 37 Wojta J, Gallicchio M, Zoellner H, Filonzi EL, Hamilton JA, and Mcgrath K. Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 1993; 81: 3285-3292
• 38 Marfaingkoka A, Devergne O, Gorgone G, Portier A, Schall TJ, Galanaud P, and Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells - Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995; 154: 1870-1878
• 39 Sironi M, Sciacca FL, Matteucci C, Conni M, Vecchi A, Bemasconi S, Minty A, Caput D, Ferrara P, Colotta F, and Mantovani A. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994; 84: 1913-1921
• 40 Garcia de Frutos P, Hardig Y, and Dahlback B. Serum amyloid P component binding to C4b-binding protein. J Biol Chem 1995; 270: 26950-26955
• 41 Hollenbaugh D, Mischel Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, and Aruffo A. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33-40
• 42 Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs A, Stem D, and Chess L. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995; 182: 1857-1864
• 43 Karmann K, Hughes CC, Schechner J, Fanslow WC, and Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 1995; 92: 4342-4346
• 44 Voest EE, Kenyon BM, O’Reilly MS, Truitt G, D’Amato RJ, and Folkman J. Inhibition of angiogenesis in vivo by interleukin-12. J Natl Cancer Inst 1995; 87: 581-586
• 45 Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, and Dinarello CA. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994; 84: 4242-4248
• 46 Brown Z, Gerritsen ME, Carley WW, Strieter RM, Kunkel SL, and Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells – Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon- gamma. Am J Pathol 1994; 145: 913-921
• 47 Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, and Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801
• 48 Schonbeck U, Brandt E, Petersen F, Flad HD, and Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995; 154: 2375-2383
• 49 Petzelbauer P, Watson CA, Pfau SE, and Pober JS. IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995; 7: 267-272
• 50 Luster AD, Greenberg SM, and Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995; 182: 219-231
• 51 Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, and Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995; 182: 155-162
• 52 Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MX, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan SY, Roczniak S, and Shanafelt AB. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270: 27348-27357
• 53 Cao YU, Chen C, Weatherbee JA, Tsang M, and Folkman J. gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J Exp Med 1995; 182: 2069-2077
• 54 Peiper SC, Wang ZJC, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogbome K, Hadley TJ, Lu ZH, Hesselgesser J, and Horuk R. The Duffy antigen receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311-1317
• 55 Rot A. Endothelial cell binding of NAP-l/IL-8: role in neutrophil emigration. Immunol Today 1992; 13: 291-294
• 56 Ley K, Baker JB, Cybulsky MI, Gimbrone MA, and Luscinskas FW. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol 1993; 151: 6347-6357
• 57 Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, and Mantovani A. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 1995; 181: 2181-2188
• 58 van Hinsbergh VW, Vermeer M, Koolwijk P, Grimbergen J, and Kooistra T. Genistein reduces tumor necrosis factor alpha- induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. Blood 1994; 84: 2984-2991
• 59 Palmer-Crocker RL, and Pober JS. IL-4 induction of VC AM-1 on endothelial cells involves activation of a protein tyrosine kinase. J Immunol 1995; 154: 2838-2845
• 60 Schieven GL, Kallestad JC, Brown TJ, Ledbetter JA, and Linsley SP. Oncostatin M induces tyrosine phosphorylation in endothelial cells and activation of p62yes tyrosine kinase. J Immunol 1992; 149: 1676-1682
• 61 Weber C, Negrescu E, Erl W, Pietsch A, Frankenberger M, Ziegler Heitbrock HW, Siess W, and Weber PC. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 1995; 155: 445-451
• 62 Modur V, Zimmerman GA, Prescott SM, and Mclntyre TM. Endothelial cell inflammatory responses to tumor necrosis factor alpha - Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem 1996; 271: 13094-13102
• 63 De Luca LG, Johnson DR, Whitley MZ, Tucker C, and Pober JS. cAMP and Tumor Necrosis Factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the Endothelial Leukocyte Adhesion Molecule-1 (E-selectin) promoter. J Biol Chem 1994; 269: 19193-19196
• 64 Whitley MZ, Thanos D, Read MA, Maniatis T, and Collins T. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol 1994; 14: 6464-6475
• 65 Kaszubska W, van Huijsduijnen RH, Ghersa P, DeRaemy Schenk AM, Chen BP, Hai T, DeLamarter JF, and Whelan J. Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol 1993; 13: 7180-7190
• 66 Pober JS, Slowik MR, De Luca LG, and Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150: 5114-5123
• 67 Ghersa P, Hooft van Huijsduijnen R, Whelan J, Cambet Y, Pescini R, and DeLamarter JF. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 1994; 269: 29129-29137
• 68 Masamune A, Igarashi Y, and Hakomori S. Regulatory role of ceramide in interleukin (IL)-l beta-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. J Biol Chem 1996; 271: 9368-9375
• 69 Wiegmann K, Schütze S, Machleidt T, Witte D, and Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in Tumor Necrosis Factor signaling. Cell 1994; 78: 1005-1015
• 70 Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, and Krönke M. FAN, a novel WD-repeat protein couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 1996; 86: 937-947
• 71 Palmer-Crocker RL, Hugles CC W, and Pober JS. IL-4 andIL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gammaC chain. J Clin Invest 1996; 98: 604-609
• 72 Verbsky JW, Bach EA, Fang YF, Yang L, Randolph DA, and Fields LE. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J Biol Chem 1996; 271: 13976-13980
• 73 Schnyder B, Lugli S, Feng N, Etter H, Lutz RA, Ryffel B, Sugamura K, Wunderli-Allenspach H, and Moser R. IL-4 and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain (gamma-c). Blood 1996; 87: 4286-4295
• 74 Soldi R, Primo L, Brizzi MF, Sanavio F, Polentarutti N, Aglietta M, Mantovani A, Pegoraro L, and Bussolino F. Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony stimulating factor. Blood. 1997. in press
• 75 Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, and Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996; 97: 1715-1722
• 76 Miyaloto S, Maki M, Schmitt MJ, Hatanaka M, and Verna M. Tumor necrosis factor alpha-induced phosphorylation of IkBalpha is signal for its degradation but not dissociation from NF-kB. Proc Natl Acad Sci USA 1994; 91: 12740-12744
• 77 Read MA, Whidey MZ, Williams AJ, and Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-512
• 78 Bennett BL, Lacson RG, Chen CC, Cruz R, Wheeler JS, Kletzien RJ, Tomasselli AG, Heinrikson RL, and Manning AM. Identification of signal-induced IkB-a kinases in human endothelial cells. J Biol Chem 1996; 271: 19680-19688
• 79 Chen CC, Rosenbloom CL, Anderson DC, and Manning AM. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol 1995; 155: 3538-3545
• 80 Johnson DR, Douglas I, Jahnke A, Ghosh S, and Pober JS. A sustained reduction in IKappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells. J Biol Chem 1996; 271: 16317-16322
• 81 Wrighton C, Hofer Warbinek RJ, Moll T, Eytner R, Bach FH, and de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IkappaBalpha, an inhibitor of the transcription factor NF-kappaB. J Exp Med 1996; 183: 1013-1022
• 82 Faruqi R, deal Motte C, and DiCorleto PE. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994; 94: 592-600
• 83 Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, and Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-1874
• 84 Orthner CL, Rodgers GM, and Fitzgerald LA. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Blood 1995; 86: 436-443
• 85 Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, and Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocytes adhesion molecule expression. Immunity 1995; 2: 493-506
• 86 de Martin.R, Vanhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H, and Bach FH. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J 1993; 12: 2773-2779
• 87 Groves RW, Giri J, Sims J, Dower SK, and Kupper TS. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implication for IL-1-mediated processes in epidermis. J Immunol 1995; 154: 4065-4072
• 88 d’Aniello EM, Breviario F, Martin Padura I, Lampugnani MG, Dejana E, Mantovani A, and Introna M. Interleukin-1 and tumor necrosis factor induce transient expression of an inhibitor of nuclear factor kB in endothelial cells. Endothelium 1993; 1: 161-165
• 89 Lindner V, and Collins T. Expression of NF-kB and IkB-alpha by aortic endothelium in an arterial injury model. Am J Pathol 1996; 148: 427-438
• 90 Dixit VM, Green S, Sarma V, Holzman LB, Wolf FW, O’Rourke K, Ward PA, Prochownik EV, and Marks RM. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 1990; 265: 2973-2978
• 91 Opipari A.W.J, Hu HM, Yabkowitz R, and Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267: 12424-12427
• 92 Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, and Ferran C. A20 bloks endothelial cell activation through a NF-kappaB-dependent machanism. J Biol Chem 1996; 271: 18068-18073
• 93 Miyagishi R, Kikuchi S, Fukazawa T, and Tashiro K. Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J Neurol Sci 1995; 129: 223-227
• 94 Ahmad M, Marui N, Alexander RW, and Medford RM. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J Biol Chem 1995; 270: 8976-8983
• 95 Schindler U, and Baichwal VR. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol 1994; 14: 5820-5831
• 96 Hooft van Huijsduijnen R, Pescini R, and DeLamarter JF. Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element. Nucleic Acids Res 1993; 21: 3711-3717
• 97 Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 09: 899-909
• 98 Pescini R, Kaszubska W, Whelan J, DeLamarter JF, and Hooft van Huijsduijnen R. ATF-aO, a novel variant of the ATF/ CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers. J Biol Chem 1994; 269: 1159-1165
• 99 Lewis H, Kaszubska W, DeLamarter JF, and Whelan J. Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine- induced expression of the E-selectin promoter. Mol Cell Biol 1994; 14: 5701-5709
• 100 Neish AS, Williams AJ, Palmer HJ, Whitley MZ, and Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 1992; 176: 1583-1593
• 101 Iademarco MF, McQuillan JJ, Rosen GD, and Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992; 267: 16323-16329
• 102 Shu HB, Agranoff AB, Nabel EG, Leung K, Duckett CS, Neish AS, Collins T, and Nabel GJ. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol Cell Biol 1993; 13: 6283-6289
• 103 Neish AS, Khachigian LM, Park A, Baichwal VR, and Collins T. Spl is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J Biol Chem 1995; 270: 28903-28909
• 104 Neish AS, Read MA, Thanos D, Pine R, Maniatis T, and Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kB as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 1995; 15: 2558-2569
• 105 Gille J, SwerlickR A, Lawley TJ, and Caughman SW. Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood 1996; 87: 211-217
• 106 Ledebur HC, and Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells - Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995; 270: 933-943
• 107 Parry GC, and Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 1994; 269: 20823-20825
• 108 Hou J, Baichwal V, and Cao Z. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1994; 91: 11641-11645
• 109 Look D, Pelletier MR, and Holtzman MJ. Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM- 1) gene promoter controls the pattern of expression on epithelial cells. J Biol Chem 1994; 269: 8952-8958
• 110 Roebuck KA, Rahman A, Lakshminarayanan V, Janakidevi K. and Malik AB. H202 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 1995; 270: 18966-18974
• 111 Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Muller M, Bohrer H, Greten J, and et a. Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem 1995; 270: 26419-26432
• 112 Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9: 883-889
• 113 Moll T, Czyz M, Holzmuller H, Hofer Warbinek R, Wagner E, Winkler H, Bach FH, and Hofer E. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Spl-like transcription factors. J Biol Chem 1995; 270: 3849-3857
• 114 Janknecht R, and Hunter TA. growing coactivator network. Nature 1996; 383: 22-23
• 115 Gearing AJ, and Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512
• 116 Lassalle P, Molet S, Janin A, Van der Heyden J, Tavernier J, Fiers W, Devos R, and Tonnel AB. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996; 271: 20458-20464